Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer

Published:2020-01 Issue: Volume:142 Page:202-209
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Jang Bum-Sup,Han Wonsik,Kim In Ah

Funder

Ministry of Science and Information & Communication Technology

SNUBH Research Fund

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference49 articles.

1. Time to abandon single-site irradiation for inducing abscopal effects;Brooks;Nat Rev Clin Oncol,2019

2. Immunotherapy for breast cancer: what are we missing?;Vonderheide;Clin Cancer Res,2017

3. Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure);Kim;Ann Oncol,2016

4. Radiotherapy and immune checkpoint blockades: a snapshot in 2016;Koo;Radiat Oncol J,2016

5. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer;Henschel;N Engl J Med,2018

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer;Progress in Biophysics and Molecular Biology;2024-05

2. Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice;Seminars in Radiation Oncology;2023-07

3. Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity;Radiation Oncology;2023-05-24

4. Development of Tumor Markers for Breast Cancer Immunotherapy;Current Molecular Medicine;2023-05-08

5. Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells;Frontiers in Oncology;2023-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3